The antiviral effects of recombinant ovine interferon-τ (roIFN-τ) were studied in 26 lambs inoculated with ovine lentivirus (OvLV) or mock-infected. Six of the OvLV-infected lambs and three of the mock-infected lambs were treated with 10 antiviral units (AVU) per kg roIFN-τ daily for 30 days starting at day 0 post-inoculation (p.i.) and twice a week thereafter (early treatment). Six of the OvLV-infected lambs and three of the mock-infected lambs were treated with 10 AVU/kg roIFN-τ daily for 30 days starting at day 150 p.i. and twice a week thereafter (late treatment). Six OvLV-infected and two mock-infected lambs were treated either early or late with placebo. Cell-associated viraemia was quantified by an end-point dilution method. The weekly antibody response against OvLV proteins was studied by ELISA. All experimental animals were killed at 27 weeks p.i. and histological sections of lung were scored for the degree of lymphoid interstitial pneumonia (LIP). A 90% reduction in OvLV titres was detected at 4 weeks post-treatment in lambs that received early roIFN-τ treatment (<0·01). Differences in virus titres were also found at weeks 2 and 6 (<0·05). Scores for LIP degree were higher in infected lambs treated with placebo or late roIFN-τ than in the mock-infected lambs or in the infected lambs that received early roIFN-τ (<0·05). LIP scores were not different between mock-infected lambs and infected lambs that received early roIFN-τ. These results indicate that roIFN-τ curtails OvLV replication and reduces the likelihood of development of lentivirus-induced LIP when infected lambs are treated during the initial phases of OvLV infection.


Article metrics loading...

Loading full text...

Full text loading...



  1. Autran, B., Carcelain, G., Li, T. S., Blanc, C., Mathez, D., Tubiana, R., Katlama, C., Debre, P. & Leibowitch, J. (1997). Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 277, 112-116.[CrossRef] [Google Scholar]
  2. Bazer, F. W. & Johnson, H. M. (1991). Type I conceptus interferons: maternal recognition of pregnancy signals and potential therapeutic agents. American Journal of Reproductive Immunology 26, 19-22.[CrossRef] [Google Scholar]
  3. Begara, I., Lujan, L., Hopkins, J., Collie, D. D., Miller, H. R. & Watt, N. J. (1995). A study on lymphocyte activation in maedi-visna virus induced pneumonia. Veterinary Immunology and Immunopathology 45, 197-210.[CrossRef] [Google Scholar]
  4. Bird, P., Reyburn, H. T., Blacklaws, B. A., Allen, D., Nettleton, P., Yirrell, D. L., Watt, N., Sargan, D. & McConnell, I. (1995). The restricted IgG1 antibody response to maedi visna virus is seen following infection but not following immunization with recombinant gag protein. Clinical and Experimental Immunology 102, 274-280. [Google Scholar]
  5. Brodie, S. J., Marcom, K. A., Pearson, L. D., Anderson, B. C., de la Concha-Bermejillo, A., Ellis, J. A. & DeMartini, J. C. (1992). Effects of virus load in the pathogenesis of lentivirus-induced lymphoid interstitial pneumonia. Journal of Infectious Diseases 166, 531-541.[CrossRef] [Google Scholar]
  6. Carpenter, C. C., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G. & Volberding, P. A. (1998). Antiretroviral therapy for HIV infection in 1998: updated recommendations of the International AIDS Society – USA Panel. Journal of the American Medical Association 280, 78-86.[CrossRef] [Google Scholar]
  7. Cavert, W., Notermans, D. W., Staskus, K., Wietgrefe, S. W., Zupancic, M., Gebhard, K., Henry, K., Zhang, Z. Q., Mills, R., McDade, H., Schuwirth, C. M., Goudsmit, J., Danner, S. A. & Haase, A. T. (1997). Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276, 960-964.[CrossRef] [Google Scholar]
  8. Cichutek, K., Merget, H., Norley, S., Linde, R., Kreuz, W., Gahr, M. & Kurth, R. (1992). Development of a quasispecies of human immunodeficiency virus type 1 in vivo. Proceedings of the National Academy of Sciences, USA 89, 7365-7369.[CrossRef] [Google Scholar]
  9. Coffin, J. M., Essex, M., Gallo, R., Graf, T. M., Hinuma, Y., Hunter, E., Jaenisch, R., Nusse, R., Oroszlan, S., Svoboda, J., Teich, N., Toyoshima, K. & Varmus, H. (1995). Family Retroviridae. In Virus Taxonomy. Sixth Report of the International Committee on Taxonomy of Viruses, pp. 193-204. Edited by F. A. Murphy, C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo & M. D. Summers. Vienna & New York: Springer-Verlag.
  10. Cutlip, R. C., Jackson, T. A. & Lehmkuhl, H. D. (1979). Lesions of ovine progressive pneumonia: interstitial pneumonitis and encephalitis.American Journal of Veterinary Research 40, 1370-1374. [Google Scholar]
  11. Cutlip, R. C., Lehmkuhl, H. D., Schmerr, M. J. & Brogden, K. A. (1988). Ovine progressive pneumonia (maedi-visna) in sheep. Veterinary Microbiology 17, 237-250.[CrossRef] [Google Scholar]
  12. Daar, E. S., Moudgil, T., Meyer, R. D. & Ho, D. D. (1991). Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. New England Journal of Medicine 324, 961-964.[CrossRef] [Google Scholar]
  13. de la Concha-Bermejillo, A. (1997). Maedi-visna and ovine progressive pneumonia. Veterinary Clinics of North America Food Animal Practice 13, 13-33. [Google Scholar]
  14. de la Concha-Bermejillo, A., Juste, R. A., Kretschmer, R. & Aguilar Setien, A. (1995a). Ovine lentivirus infection: an animal model for pediatric HIV infection. Archives of Medical Research 26, 345-354. [Google Scholar]
  15. de la Concha-Bermejillo, A., Brodie, S. J., Magnus-Corral, S., Bowen, R. A. & DeMartini, J. C. (1995b). Pathologic and serologic responses of isogeneic twin lambs to phenotypically distinct lentiviruses. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8, 116-123. [Google Scholar]
  16. DeMartini, J. C., Brodie, S. J., de la Concha-Bermejillo, A., Ellis, J. A. & Lairmore, M. D. (1993). Pathogenesis of lymphoid interstitial pneumonia in natural and experimental ovine lentivirus infection. Clinical Infectious Diseases 17 (Suppl. 1), S236–S242.[CrossRef] [Google Scholar]
  17. Dereuddre-Bosquet, N., Clayette, P., Martin, M., Mabondzo, A., Fretier, P., Gras, G., Martal, J. & Dormont, D. (1996). Anti-HIV potential of a new interferon, interferon-τ (trophoblastin). Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11, 241-246.[CrossRef] [Google Scholar]
  18. Ellis, J. A. & DeMartini, J. C. (1985a). Ovine interleukin-2: partial purification and assay in normal sheep and sheep with progressive pneumonia. Veterinary Immunology and Immunopathology 8, 15-25.[CrossRef] [Google Scholar]
  19. Ellis, J. A. & DeMartini, J. C. (1985b). Evidence of decreased concanavalin A induced suppressor cell activity in the peripheral blood and pulmonary lymph nodes of sheep with ovine progressive pneumonia. Veterinary Immunology and Immunopathology 8, 93-106.[CrossRef] [Google Scholar]
  20. Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., Gallant, J., Markowitz, M., Ho, D. D., Richman, D. D. & Siliciano, R. F. (1997). Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278, 1295-1300.[CrossRef] [Google Scholar]
  21. Francis, M. L., Meltzer, M. S. & Gendelman, H. E. (1992). Interferons in the persistence, pathogenesis, and treatment of HIV infection. AIDS Research and Human Retroviruses 8, 199-207.[CrossRef] [Google Scholar]
  22. Gendelman, H. E., Baca, L., Turpin, J. A., Chester Kalter, D., Hansen, B. D., Orenstein, J. M., Friedman, R. M. & Meltzer, M. S. (1990). Restriction of HIV replication in infected T cells and monocytes by interferon-α. AIDS Research and Human Retroviruses 6, 1045-1049. [Google Scholar]
  23. Haase, A. T., Henry, K., Zupancic, M., Sedgewick, G., Faust, R. A., Melroe, H., Cavert, W., Gebhard, K., Staskus, K., Zhang, Z. Q., Dailey, P. J., Balfour, H. H.Jr, Erice, A. & Perelson, A. S. (1996). Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274, 985-989.[CrossRef] [Google Scholar]
  24. Ho, D. D. (1996). Viral counts count in HIV infection. Science 272, 1124-1125.[CrossRef] [Google Scholar]
  25. Joshi, V. V., Oleske, J. M., Klein, K. M., Dadzie, C., Simpser, M. & Rapkin, R. H. (1985). Pathologic pulmonary findings in children with the acquired immunodeficiency syndrome: a study of ten cases. Human Pathology 16, 241-246.[CrossRef] [Google Scholar]
  26. Joshi, V. V., Oleske, J. K. & Connor, E. M. (1990). Morphologic findings in children with acquired immunodeficiency syndrome: pathogenesis and clinical implications. Pediatric Pathology 10, 155-165.[CrossRef] [Google Scholar]
  27. Juste, R. A., Ott, T. L., Kwang, J., Bazer, F. W. & de la Concha-Bermejillo, A. (1996). Effects of recombinant interferon-τ on ovine lentivirus replication. Journal of Interferon and Cytokine Research 16, 989-994. [Google Scholar]
  28. Juste, R. A., Kwang, J. & de la Concha-Bermejillo, A. (1998). Dynamics of cell-associated viremia and antibody response during the early phase of lentivirus infection in sheep. American Journal of Veterinary Research 59, 563-568. [Google Scholar]
  29. Katzenstein, D. A., Hammer, S. M., Hughes, M. D., Gundacker, H., Jackson, J. B., Fiscus, S., Rasheed, S., Elbeik, T., Reichman, R., Japour, A., Merigan, T. C. & Hirsch, M. S. (1996). The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. New England Journal of Medicine 335, 1091-1098.[CrossRef] [Google Scholar]
  30. Kornbluth, R. S., Oh, P. S., Munis, J. R., Cleveland, P. H. & Richman, D. D. (1990). The role of interferons in the control of HIV replication in macrophages. Clinical Immunology and Immunopathology 54, 200-219.[CrossRef] [Google Scholar]
  31. Koup, R. A. & Ho, D. D. (1994). Shutting down HIV.Nature 370, 416.[CrossRef] [Google Scholar]
  32. Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. & Ho, D. D. (1994). Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. Journal of Virology 68, 4650-4655. [Google Scholar]
  33. Kunzi, M. S., Farzadegan, H., Margolick, J. B., Vlahov, D. & Pitha, P. M. (1995). Identification of human immunodeficiency virus primary isolates resistant to interferon-α and correlation of prevalence to disease progression. Journal of Infectious Diseases 171, 822-828.[CrossRef] [Google Scholar]
  34. Kwang, J., Keen, J., Cutlip, R. C. & Littledike, E. T. (1993). Evaluation of an ELISA for detection of ovine progressive pneumonia antibodies using a recombinant transmembrane envelope protein. Journal of Veterinary Diagnostic Investigation 5, 189-193.[CrossRef] [Google Scholar]
  35. Lairmore, M. D., Poulson, J. M., Adducci, T. A. & DeMartini, J. C. (1988). Lentivirus-induced lymphoproliferative disease. Comparative pathogenicity of phenotypically distinct ovine lentivirus strains. American Journal of Pathology 130, 80-90. [Google Scholar]
  36. Lane, H. C. (1991). The role of α-interferon in patients with human immunodeficiency virus infection. Seminars in Oncology 18 (Suppl. 7), 46–52. [Google Scholar]
  37. Lane, H. C., Davey, V., Kovacs, J. A., Feinberg, J., Metcalf, J. A., Herpin, B., Walker, R., Deyton, L., Davey, R. T. J. & Falloon, J. (1990). Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial. Annals of Internal Medicine 112, 805-811.[CrossRef] [Google Scholar]
  38. Levy, J. A. (1993). Pathogenesis of human immunodeficiency virus infection. Microbiology Reviews 57, 183-289. [Google Scholar]
  39. Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A. & Kingsley, L. A. (1996). Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 272, 1167-1170.[CrossRef] [Google Scholar]
  40. Myer, M. S., Huchzermeyer, H. F., York, D. F., Hunter, P., Verwoerd, D. W. & Garnett, H. M. (1988). The possible involvement of immunosuppression caused by a lentivirus in the aetiology of jaagsiekte and pasteurellosis in sheep. Onderstepoort Journal of Veterinary Research 55, 127-133. [Google Scholar]
  41. O’Brien, W. A., Hartigan, P. M., Daar, E. S., Simberkoff, M. S. & Hamilton, J. D. (1997). Changes in plasma HIV RNA levels and CD4+ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. VA Cooperative Study Group on AIDS. Annals of Internal Medicine 126, 939-945.[CrossRef] [Google Scholar]
  42. Ott, T. L., van Heeke, G., Johnson, H. M. & Bazer, F. W. (1991). Cloning and expression in Saccharomyces cerevisiae of a synthetic gene for the type-I trophoblast interferon ovine trophoblast protein-1: purification and antiviral activity. Journal of Interferon Research 11, 357-364.[CrossRef] [Google Scholar]
  43. Pantaleo, G., Graziosi, C. & Fauci, A. S. (1993). The immunopathogenesis of human immunodeficiency virus infection. New England Journal of Medicine 328, 327-335.[CrossRef] [Google Scholar]
  44. Pantaleo, G., Demarest, J. F., Soudeyns, H., Graziosi, C., Denis, F., Adelsberger, J. W., Borrow, P., Saag, M. S., Shaw, G. M., Sekaly, R. P. & Fauci, A. S. (1994). Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 370, 463-467.[CrossRef] [Google Scholar]
  45. Petursson, G., Andresdottir, V., Andresson, O. S., Georgsson, G., Palsson, P. A., Rafnar, B. & Torsteinsdottir, S. (1992). Lentivirus diseases of sheep and goats: maedi-visna and caprine arthritis encephalitis. In Progress in Sheep and Goat Research, pp. 107-129. Edited by A. W. Speedy. Wallingford, UK: CAB International.
  46. Pontzer, C. H., Torres, B. A., Vallet, J. L., Bazer, F. W. & Johnson, H. M. (1988). Antiviral activity of the pregnancy recognition hormone ovine trophoblast protein-1.Biochemical and Biophysical Research Communications 152, 801-807.[CrossRef] [Google Scholar]
  47. Pontzer, C. H., Bazer, F. W. & Johnson, H. M. (1991). Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Research 51, 5304-5307. [Google Scholar]
  48. Pontzer, C. H., Yamamoto, J. K., Bazer, F. W., Ott, T. L. & Johnson, H. M. (1997). Potent anti-feline immunodeficiency virus and anti-human immunodeficiency virus effect of IFN-tau. Journal of Immunology 158, 4351-4357. [Google Scholar]
  49. Pyrah, I. T. G. & Watt, N. J. (1996). Immunohistological study of the depressed cutaneous DTH response in sheep naturally infected with an ovine lentivirus (maedi-visna virus). Clinical and Experimental Immunology 104, 32-36.[CrossRef] [Google Scholar]
  50. Rivero, J., Fraga, M., Cancio, I., Cuervo, J. & Lopez-Saura, P. (1997). Long-term treatment with recombinant interferon alpha-2b prolongs survival of asymptomatic HIV-infected individuals. Biotherapy 10, 107-113.[CrossRef] [Google Scholar]
  51. Scott, G. B. (1991). HIV infection in children: clinical features and management. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 4, 109-115. [Google Scholar]
  52. Simberkoff, M. S., Hartigan, P. M., Hamilton, J. D., Day, P. L., Diamond, G. R., Dickinson, G. M., Drusano, G. L., Egorin, M. J., George, W. L., Gordin, F. M., Hawkes, C. A., Jensen, P. C., Kilmas, N. G., Labriola, A. M., O’Brien, W. A., Oster, C. N., Weinhold, K. J., Wray, N. P. & Pazner, S. B. (1996). Long-term follow-up of symptomatic HIV-infected patients originally randomized to early versus later zidovudine treatment; report of a Veterans Affairs Cooperative Study. VA Cooperative Study Group on AIDS Treatment.Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11, 142-150.[CrossRef] [Google Scholar]
  53. Singh, B., Ott, T. L., Bazer, F. W. & de la Concha-Bermejillo, A. (1998). Structural responses of pulmonary intravascular macrophages in lentivirus-infected and/or recombinant ovine interferon-τ-treated lambs. Anatomical Record 251, 472-485.[CrossRef] [Google Scholar]
  54. Stuart-Harris, R. C., Lauchlan, R. & Day, R. (1992). The clinical application of the interferons: a review. Medical Journal of Australia 156, 869-872. [Google Scholar]
  55. Villegas, P. & Purchase, H. G. (1989). Titration of biological suspensions. In A Laboratory Manual for the Isolation and Identification of Avian Pathogens, pp. 186-191. Edited by H. G. Purchase, L. H. Arp, C. H. Domermuth & J. E. Pearson. Dubuque, IA: Kendall/Hunt Publishing.
  56. Woodward, T. M., Carlson, J. O., de la Concha-Bermejillo, A. & DeMartini, J. C. (1995). Biological and genetic changes in ovine lentivirus strains following passage in isogeneic twin lambs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 8, 124-133. [Google Scholar]

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error